Sarcoplasmic lipase and non-specific esterase inhibition in myofibers of rats intoxicated with the organophosphate isofenphos

Experimental and Toxicologic Pathology

Volumn 51, Issue 1, 1999, Pages 27-33

  Calore, Edenilson Eduardo ^a   Sesso, A ^d   Puga, F R ^b   Cavaliere, M J ^c   Calore, N M P ^a   Weg, R ^a  

^a INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^b INSTITUTO BIOLÓGICO   (Brazil)

^c INSTITUTO ADOLFO LUTZ   (Brazil)

^d Section of Pathology ^*

Author keywords

Esterases, myofibers; Isophenos; Lipase, sarcoplasmic; Lipid content, myofibers; Muscle fibers; Myofibers, lipases, esterases, lipid content; Organophosphate; Sarcoplasmic lipase

Indexed keywords

CHOLINESTERASE; ESTERASE; FAT DROPLET; ISOFENPHOS; LIPID; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; DIAPHRAGM MUSCLE; ENZYME INHIBITION; INTOXICATION; MALE; MUSCLE MITOCHONDRION; MUSCLE NECROSIS; NONHUMAN; RAT; SARCOPLASM;

ANIMALIA;

EID: 0032957580     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(99)80054-2     Document Type: Article

References (21)

1. ARIENS AT, MEETER E, WOLHIUS OL, et al.: Reversible necrosis at the endplate region in striated muscles of the rat poisoned with cholinesterase inhibitors. Experientia 1969; 25: 57-59.
2. BRIGTH JE, INNS RH, TUCKWELL NJ, et al.: A histochemical study of changes observed in the mouse diaphragm after organophosphate poisoning. Hum Exp Toxicol 1991; 10: 9-14.
3. CHRISTIAN DR, KILSHEIMER GS, PETTETT G, et al.: Regulation of lipolysis in cardiac muscle: A system similar to the hormone-sensitive lipase of adipose tissue. Adv Enzyme Regul 1969; 7: 71.
4. COLEMAN RA, HAYNES EB: Differentiation of microsomal from lysosomal triglycerol lipase activities in rat liver. Biochim Biophys Acta 1983; 751: 230.
5. DAVIS BJ, ORNSTEIN L: High resolution enzyme localization with a new diazo reagent, "hexazonium pararosaniline" J Histochem 1959; 7: 298.
6. DE BLEECKER JL, WILLEMS J, DE REUCK J, et al.: Histological and histochemical study of paraoxon myopathy in the rat. Acta Neurol Belg 1991; 91: 255-270.
7. DE BLEECKER JL, VAN DEN ABEELE KG, DE REUCK JL: Variable muscle involvement of rat skeletal muscle in paraoxon-induced necrotizing myopathy. Res Chem Pathol Com Pharmacol 1992; 75: 309-322.
8. DEKLEVA A, SKET D, SKETLJ J, BRZIN M: Attenuation of soman-induced lesions of skeletal muscle by acetylcholinesterase reactivating and non-reactivating antidotes. Acta Neuropathol 1989; 79: 183-189.
9. ELLMAN GL, COUTNEY KD, ANDRES JrV, et al.: A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
10. FENICHEL GM, KIBLER WB, WILLIAM H, et al.: Chronic inhibition of cholinesterase as a cause of myopathy. Neurology 1972; 22: 1026-1033.
11. FREDRIKSON G, STRALFORS P, NILSSON NO, et al.: Positional specificity of hormone-sensitive lipase from rat adipose tissue. J Biol Chem 1981; 256: 6311-6320.
12. GOMORI G: Histochemistry of esterases. Internat Rev Cytol 1952; 1: 323.
13. HAYASE K, TAPPEL AL: Specificity and other properties of lysosomal lipase of rat liver. J Biol Chem 1970; 245:169.
14. KNAUER TE, WEGLICKI WB: Characteristics of multiple forms of the acidic triglycerol lipase(s) of canine cardiac myocytes. Biochim Biophys Acta 1983; 753: 173.
15. KREISBERG RA: Effects of epinephrine on myocardial triglyceride and free fatty acid utilization. Am J Phisiol 1966; 210: 385.
16. ROUND JM, MATTHEWS Y, JONES DA: A quick simple and reliable method for ATPase in human muscle preparations. Histochem J 1980; 12: 707-709.
17. SANDO GN and ROSENBAUN LM: Human lysosomal acid/ cholesteryl ester hydrolase. Purification and properties of the form secreted by fibroblasts in microcarrier culture. J Biol Chem 1985; 260: 15186-93.
18. THOMPSON WR: Use of moving averages and interpolation to estimate median effective doses. Bacteriol Ret 1947; 11: 115-145.
19. WECKER L, DETTBARN W-D: Effects of denervation on the production of an experimental myopathy. Exp Neurol 1977; 57: 96-100.
20. WEILL CS: Tables for convenient calculation of median effective doses (LD 50 or ED50), and instruction in their use. Biometrics 1952; 8: 249-463.
21. WILHEIM K: Determination of human plasma cholinesterase activity by adapted Ellman method. Arh Hig Rad Tokskol 1967; 19: 199-207.